Pages
Products

CMV FLuc Reporter Lentivirus

For research use only. Not intended for any clinical use.

Cat. No. :   LVG00119Z

Storage :   -80℃ Shipping :   Frozen on dry ice

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Cat. No. LVG00119Z
Description Lentivirus particles containing firefly luciferase reporter gene under the control of CMV promoter.
Titer Varies lot by lot, for example, ≥1*10^7 TU/mL, ≥1*10^8 TU/mL, ≥1*10^9 TU/mL etc.
Size Varies lot by lot, for example, 100 ul, 500 ul, 1 mL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Summary Creative Biogene ensures high-quality lentivirus particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between lentivirus particle lots.
Mycoplasma Creative Biogene routinely tests for mycoplasma contamination using a mycoplasma detection kit. Cell lines are maintained for approximately 20 passages before being discarded and replaced with a new vial of early passage cells. Approximately 2 weeks after thawing, cell culture supernatants are tested for mycoplasma contamination. Creative Biogene ensures that lentiviral products are free of mycoplasma contamination.
Purity Creative Biogene evaluates the level of impurities, such as residual host cell DNA or proteins, in prepared lentiviral vectors to ensure they meet quality standards.
Sterility The lentiviral samples were inoculated into cell culture medium for about 5 days and the growth of bacteria and fungi was tested. Creative Biogene ensures that the lentiviral products are free of microbial contamination.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of lentivirus to deliver genetic material into target cells, and assess gene expression and functional activities.
Proviral Identity Confirmation All Creative Biogene lentiviral vectors are confirmed to have correctly integrated provirus using PCR. This test involves transducing cells with serial dilutions of the lentiviral vector, harvesting the cells a few days later, and isolating genomic DNA. This DNA is then used as a template to amplify a portion of the expected lentiviral insert.
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

The CMV FLuc reporter lentivirus is a recombinant lentiviral vector genetically engineered to express the firefly luciferase (FLuc) gene under the control of the human cytomegalovirus (CMV) immediate-early promoter. This powerful tool is designed to achieve stable gene delivery and long-term expression in a variety of mammalian cell types, including dividing and non-dividing cells. The lentiviral backbone ensures efficient integration into the host genome, resulting in sustained FLuc expression, while the CMV promoter drives high levels of transcriptional activity in a variety of cell types. The firefly luciferase reporter gene enables non-invasive quantitative monitoring of gene expression in vitro and in vivo using bioluminescence imaging (BLI).

The CMV FLuc reporter lentivirus is widely used in biomedical research due to its versatility and high sensitivity. It serves as a reliable reporter gene in cell-based assays to study promoter activity, signaling pathways, and gene regulation. Researchers can quantify luciferase activity to assess the effects of drugs, cytokines, or genetic modifications on cellular processes. For in vivo imaging, FLuc-expressing cells or tissues can be tracked in animal models, enabling real-time visualization of tumor growth, metastasis, or stem cell migration. Lentiviral vectors can also be used for gene therapy development. Their compatibility with high-throughput screening further facilitates drug discovery and functional genomics projects.

The skin is an easily accessible organ, and transferring therapeutic genes to the skin remains an attractive alternative approach for the treatment of skin diseases. Although efficient lentiviral gene delivery to human skin has been documented previously, adeno-associated virus (AAV)-based vectors are one of the most promising gene delivery tools for in vivo purposes. Here, researchers compared recombinant AAV vectors of various serotypes and lentiviral vectors for potential use in gene transfer to human skin in a xenograft mouse model. Vector constructs encoding firefly luciferase were packaged in AAV capsids of serotypes 1, 2, 5, 6, 8, and 9 and administered individually in human skin grafts by intradermal injection. For all serotypes, live bioimaging revealed low levels of transgene expression in human skin grafts, and firefly luciferase expression was primarily observed in adjacent tissues outside the graft. In contrast, gene delivery efficiency was high with intradermal injection of lentiviral vectors and resulted in widespread and persistent expression of firefly luciferase exclusively within human skin grafts. This study demonstrates that single-stranded AAV vectors of six commonly used serotypes have limited ability to deliver genes to human skin in vivo.

Here, researchers show that lentiviral vectors are able to transduce human skin cells within the injected graft, whereas rAAV vectors (whose potency varies by serotype) primarily transduce cells outside the graft. To confirm this finding, experiments comparing the efficacy of LV/CMV-FLuc and rAAV2/6-CMV-FLuc were repeated in a larger group of mice (n=5). Importantly, a strong bioluminescent signal was observed in all mice treated with rAAV2/6-CMV-Fluc in this experiment, while the signal intensity in LV/CMV-FLuc-injected mice was lower but clearly restricted to the graft (Figure 1a). Next, grafts were isolated from all 10 mice and the expression topology within the graft was analyzed (Figure 1b). For grafts from all five mice injected with LV/CMV-FLuc, the researchers confirmed strong gene expression centered inside the graft, whereas the remaining expression for rAAV2/6-CMV-FLuc-injected grafts was detected only in the periphery of the graft and most likely in neighboring connective tissue attached to the isolated graft.

Figure 1. rAAV2/6 transduction of neighboring tissues but not of the skin graft after intradermal vector injection.Figure 1. rAAV2/6 transduction of neighboring tissues but not of the skin graft after intradermal vector injection. (Jakobsen M, et al., 2015)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Excellent product

Excellent product! We observed strong and stable FLuc expression under CMV promoter control, with minimal batch-to-batch variability. Perfect for long-term studies.

United Kingdom

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction